Ingkapairoj, Navakorn
(Department of Obstetrics and Gynecology, Faculty of Medicine, Khon Kaen University)
Luanratanakorn, Sanguanchoke (Department of Obstetrics and Gynecology, Faculty of Medicine, Khon Kaen University) Chumworathayi, Bandit (Department of Obstetrics and Gynecology, Faculty of Medicine, Khon Kaen University) Kietpeerakool, Chumnan (Department of Obstetrics and Gynecology, Faculty of Medicine, Khon Kaen University) Supoken, Amornrat (Department of Obstetrics and Gynecology, Faculty of Medicine, Khon Kaen University) |
1 | Errington CA, Roberts M, Tindle P, et al (2006). Colposcopic management of high-grade referral smears: a retrospective audit supporting 'see and treat'? Cytopathology, 17, 339-47. DOI ScienceOn |
2 | Holschneider CH, Ghosh K, Montz FJ (1999). See-and-treat in the management of high-grade squamous intraepithelial lesions of the cervix: a resource utilization analysis. Obstet Gynecol, 94, 377-85. DOI |
3 | Kietpeerakool C, Cheewakriangkrai C, Suprasert P, et al (2009). Feasibility of the 'see and treat' approach in management of women with 'atypical squamous cell, cannot exclude high-grade squamous intraepithelial lesion' smears. J Obstet Gynaecol Res, 35, 507-13. DOI ScienceOn |
4 | Kietpeerakool C, Srisomboon J (2010). Is the "see and treat" approach appropriate for management of women with abnormal cervical cytology in Thailand? Thai J Obstet Gynaecol, 18, 45-53. |
5 | Kietpeerakool C, Srisomboon J, Khunamornpong S, et al (2007). How can the overtreatment rate of "see and treat" approach be reduced in women with high-grade squamous intraepithelial lesion on cervical cytology? Asian Pac J Cancer Prev, 8, 206-8. |
6 | Kyrgiou M, Tsoumpou I, Vrekoussis T, et al (2006). The up to-date evidence on colposcopy practice and treatment of cervical intraepithelial neoplasia: the Cochrane colposcopy and cervical cytopathology collaborative group (C5 group) approach. Cancer Treat Rev, 32, 516-23. DOI ScienceOn |
7 | Luesley D, Leeson S (2010). Colposcopy and Programme Management.Guidelines for the NHS Cervical Screening Programme. NHSCSP Publication, no. 20. Sheffield, UK:NHSCSP;2010. |
8 | Numnum TM, Kirby TO, Leath CA, et al (2005). A prospective evaluation of "see and treat" in women with HSIL Pap smear results: is this an appropriate strategy? J Low Genit Tract Dis, 9, 2-6. DOI ScienceOn |
9 | Wright TC Jr, Massad LS, Dunton CJ, et al (2007). 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests. Am J Obstet Gynecol, 197, 346-55. DOI ScienceOn |
10 | Wright TC, Ronnett BM, Ferenczy A (2011). Precancerous lesions of the cervix. In Kurman RJ, Ellerson L H. Ellenson, Ronnett BM (Eds.), Blaustein's pathology of the female genital tract (sixth ed). Baltimore: Springer.pp.193-254 |
11 | Aue-Aungkul A, Punyawatanasin S, Natprathan A, et al (2011). "See and treat" approach is appropriate in women with highgrade lesions on either cervical cytology or colposcopy. Asian Pac J Cancer Prev, 12, 1723-6. |
12 | Balasubramani L, Orbell S, Hagger M, et al (2007). Do women with high-grade cervical intraepithelial neoplasia prefer a see and treat option in colposcopy? BJOG, 114, 39-45. |
13 | Charoenkwan K, Srisomboon J, Siriaunkgul S, et al (2004). A "See and Treat" approach for high grade squamous intraepithelial lesion on cervical cytology. J Med Assoc Thai, 87, 865-8. |